Hematologic Malignancy
AL Amyloidosis
CI-CAN-00008703Explore in graph →
HematologicNon-malignant31 active trials
- NCIt
- C158963
- MeSH
- D000075363
Loading cancer entity…
Hematologic Malignancy
CI-CAN-00008703Explore in graph →
Clinical trials
79 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07215494 | A Clinical Study on Minimal Residual Disease in Patients With Systemic Light Chain Amyloidosis | recruiting | N/A | 50 | Peking University First HospitalOTHER | 1 | Sep 16, 2026 | clinicaltrials |
| NCT06192979 | Optimize First-line Treatment for AL Amyloidosis With t (11; 14) | recruiting | N/A | 41 | Jin Lu, MDOTHER | 1 | Jul 7, 2026 | clinicaltrials |
| NCT06971848 |
| Evaluation of Skin Tests in Biotherapy Allergies(ETCABIO) |
| recruiting |
| N/A |
| 70 |
| University Hospital, AngersOTHER_GOV |
| 1 |
| Jun 18, 2026 |
| clinicaltrials |
| NCT07624760 | Early Detection of Amyloidosis in Monoclonal Gammopathy Using Nuclear Medicine Imaging(MGUS-PET) | not yet recruiting | N/A | 50 | University of ZurichOTHER | 1 | Jun 3, 2026 | clinicaltrials |
| NCT06769555 | BCMA/CD3 BiTE for RRAL or NDAL Amyloidosis With Insufficient Depth of Hematologic Response After Induction Therapy | withdrawn | N/A | 0 | Institute of Hematology & Blood Diseases Hospital, ChinaOTHER | 0 | Apr 29, 2026 | clinicaltrials |
| NCT04392960 | Novel Imaging Tools in Newly-diagnosed Patients With Cardiac AL Amyloidosis | completed | N/A | 30 | Fondazione IRCCS Policlinico San Matteo di PaviaOTHER | 1 | Apr 16, 2026 | clinicaltrials |
| NCT01758042 | Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood Disorders(BMT) | completed | N/A | 10 | Massachusetts General HospitalOTHER | 1 | Mar 6, 2026 | clinicaltrials |
| NCT06699394 | Prospective Study of Teclistamab in the Treatment of Systemic AL Amyloidosis | recruiting | N/A | 20 | Peking University People's HospitalOTHER | 1 | Apr 24, 2025 | clinicaltrials |
| NCT06376214 | Daratumumab for Patients With Light Chain Amyloidosis | recruiting | N/A | 100 | Nanjing University School of MedicineOTHER | 1 | Apr 19, 2024 | clinicaltrials |
Data updated 14 days agoSource updated Sep 16, 2026source: clinicaltrials